Bblueprint
Iambic Therapeutics connects molecular AI with experimental drug discovery
Explore Iambic’s Enchant and NeuralPLexer, automated discovery loop and partnership models, with a proposed evaluation and evidence limits.
Models & infrastructureWed, 23 Sept 2026
8 minread

